Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

PFE

Pfizer Inc

Mar 12 • 04:00PM ET

26.86

-0.44 -1.61 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN-D

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Index	S&P 500	P/E	19.82	EPS (ttm)	1.36	Insider Own	0.10%	Shs Outstand	5.69B	Perf Week	0.94%
Market Cap	152.73B	Forward P/E	9.51	EPS next Y	2.83	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	-2.72%
Enterprise Value	206.85B	PEG	-	EPS next Q	0.73	Inst Own	67.06%	Short Float	2.51%	Perf Quarter	6.04%
Income	7.75B	P/S	2.44	EPS this Y	-8.21%	Inst Trans	0.28%	Short Ratio	3.00	Perf Half Y	9.32%
Sales	62.58B	P/B	1.77	EPS next Y	-4.40%	ROA	3.67%	Short Interest	142.85M	Perf YTD	7.87%
Book/sh	15.21	P/C	11.23	EPS next 5Y	-8.90%	ROE	8.87%	52W High	27.94 -3.87%	Perf Year	4.47%
Cash/sh	2.39	P/FCF	16.83	EPS past 3/5Y	-37.19% -3.57%	ROIC	5.15%	52W Low	20.92 28.42%	Perf 3Y	-31.81%
Dividend Est.	1.75 (6.52%)	EV/EBITDA	8.58	Sales past 3/5Y	-14.56% 8.48%	Gross Margin	66.23%	Volatility	2.51% 2.04%	Perf 5Y	-23.13%
Dividend TTM	1.72 (6.40%)	EV/Sales	3.31	EPS Y/Y TTM	-3.74%	Oper. Margin	27.99%	ATR (14)	0.61	Perf 10Y	-7.07%
Dividend Ex-Date	Jan 23, 2026	Quick Ratio	0.87	Sales Y/Y TTM	-1.65%	Profit Margin	12.38%	RSI (14)	50.00	Recom	2.59
Dividend Gr. 3/5Y	2.23% 2.37%	Current Ratio	1.16	EPS Q/Q	-509.90%	SMA20	-0.81%	Beta	0.41	Target Price	28.35
Payout	126.85%	Debt/Eq	0.78	Sales Q/Q	-1.16%	SMA50	1.73%	Rel Volume	0.81	Prev Close	27.30
Employees	75000	LT Debt/Eq	0.74	Earnings	Feb 03 BMO	SMA200	6.63%	Avg Volume	47.56M	Price	26.86
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.42% 4.20%	Trades		Volume	38,473,330	Change	-1.61%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-02-26	Upgrade	Argus	Hold → Buy	$35
Feb-25-26	Initiated	RBC Capital Mkts	Underperform	$25
Feb-20-26	Initiated	Barclays	Underweight	$25
Feb-12-26	Downgrade	Daiwa Securities	Outperform → Neutral	$27
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50

Show Previous Ratings

Today 10:28AM	Starboard Value Is Betting Big on This Blue-Chip Dividend Stock. Should You? (Barchart)
07:00AM	The Best Covered Call Strategy to Trade High-Yielding Pfizer Stock and Earn Extra Income (Barchart)
Mar-11-26 12:41PM	Be nimble, be ready: how to tackle regulatory uncertainty in clinical trials (Clinical Trials Arena)
Mar-10-26 04:20PM	Why BridgeBio Leapfrogged Its 50-Day Line On Pfizer's Patent Shake-Up (Investor's Business Daily)
03:00PM	BioNTech SE (BNTX) Q4 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue Challenges (GuruFocus.com)
02:49PM	Loading…
02:49PM	BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz (Benzinga)
09:24AM	BioNTech Reports Earnings. That's Not Why the Stock Is Down 17%. (Barrons.com)
08:40AM	BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture (Benzinga)
08:19AM	BioNTechs Founding Duo Will Leave to Start New mRNA Firm (Bloomberg)
07:18AM	BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. (Barrons.com)
07:00AM	Xenon hits a home run in epilepsy; FDA restarts review of Duchenne cell therapy (BioPharma Dive)
Mar-09-26 02:14PM	Roches oral SERD fails in Phase III breast cancer trial (Clinical Trials Arena)
01:42PM	Factbox-Global drugmakers rush to boost US presence as tariff threat looms (Reuters)
12:22PM	Why Is Olema Pharmaceuticals Stock Dropping On Monday? (Benzinga)
10:21AM	Roche Shares Drop Up to 7.5% After Breast Cancer Pill Misses Trial Goal (GuruFocus.com)
08:19AM	Loading…
08:19AM	Roches prized breast cancer pill fails closely watched study (BioPharma Dive)
07:42AM	Stocks to Watch Monday: Moderna, Live Nation, Pfizer, Hims & Hers (The Wall Street Journal)
06:45AM	Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis (Business Wire)
05:44AM	Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study (The Wall Street Journal)
05:43AM	Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer, Hims & Hers (The Wall Street Journal)
Mar-08-26 04:49PM	These 8 drugs could help fight dementia - and they're already on the market (MarketWatch)
Mar-07-26 12:26PM	C4 Therapeutics Maps Accelerated Approval Path for Myeloma Drug Cemsidomide at TD Cowen Conference (MarketBeat)
Mar-06-26 11:30AM	AbbVie (ABBV) Up 6.1% Since Last Earnings Report: Can It Continue? (Zacks)
09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:14AM	China Clears Weight-Loss Shot As Pfizer Enters Crowded Market (Benzinga)
05:13AM	Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs (BioPharma Dive)
03:53AM	BridgeBio Pharma Talks Atrubie Momentum, Phase 3 Wins as Tafamidis IP Trial Looms (MarketBeat)
Mar-05-26 11:30AM	Pfizer (PFE) Down 0.6% Since Last Earnings Report: Can It Rebound? (Zacks)
08:45AM	Can Pfizer Reignite Growth Amid COVID Declines and Patent Expirations? (Zacks)
Mar-04-26 08:54PM	Argus Turns Bullish on Pfizer (PFE), Highlights GLP-1 and Oncology Pipeline (Insider Monkey)
10:36AM	Loading…
10:36AM	Arvinas Highlights Growing Phase 1 Pipeline, Near-Term Catalysts at TD Cowen Healthcare Conference (MarketBeat)
08:55AM	NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals (PR Newswire)
12:48AM	Pfizer Inc. (PFE) and Astellas Report Positive Phase 3 EV-304 Results for PADCEV Plus Keytruda in Bladder Cancer (Insider Monkey)
Mar-03-26 07:24PM	Analyst Report: ICU Medical, Inc. (Morningstar Research)
03:35PM	The Dividend Safe Harbor: 2 Stocks to Watch (MarketBeat)
09:10AM	Immunology, Neuroscience Step Up as Key Growth Engines for J&J (Zacks)
Mar-02-26 12:42PM	BMY Gains 11.4% in a Month: Should You Buy, Sell or Hold the Stock? (Zacks)
11:00AM	Pfizer Stock: Buy, Sell or Hold After Its 11% Rally So Far in 2026? (Zacks)
09:53AM	Netflix upgraded, Pinterest downgraded: Wall Street's top analyst calls (The Fly)
Mar-01-26 04:27AM	Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM (Insider Monkey)
Feb-27-26 10:30AM	The Zacks Analyst Blog Highlights Meta Platforms, Netflix, Pfizer, SIFCO Industries and Altigen Communications (Zacks)
10:24AM	Amneal Pharmaceuticals Q4 Earnings Call Highlights (MarketBeat)
10:00AM	PADCEV + Keytruda Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer (Business Wire)
08:26AM	Novavax Stock Gains as Q4 Earnings & Sales Beat Estimates (Zacks)
07:01AM	Pfizer (PFE) Secures Full FDA Approval for BRAFTOVI as First-Line Treatment in mCRC (Insider Monkey)
12:07AM	Novavax Q4 Earnings Call Highlights (MarketBeat)
Feb-26-26 07:30PM	Love Dividends? 1 Stock to Buy Now With a Yield Over 6%. (Barchart)
04:11PM	Novavax Inc (NVAX) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... (GuruFocus.com)
04:11PM	Top Research Reports for Meta, Netflix & Pfizer (Zacks)
02:24PM	Analyst Report: Viatris Inc. (Morningstar Research)
10:59AM	Aclaris Therapeutics Highlights AD and Asthma Data Catalysts at Oppenheimer Healthcare Conference (MarketBeat)
08:46AM	Novavax shares subdued despite earnings, revenue beat (Investing.com)
08:30AM	Novavax, Inc. Q4 2025 Earnings Call Summary (Moby)
04:32AM	Cardiff Oncology Spotlights Onvansertib Data at Oppenheimer: 72% ORR in RAS-Mutant mCRC (MarketBeat)
Feb-25-26 09:50PM	RBC Capital Initiates Pfizer (PFE) with $25 Target, Warns of Structural Revenue Headwinds (Insider Monkey)
01:22PM	Pfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment (Benzinga)
01:20PM	Analyst Report: Haleon plc (Morningstar Research)
11:33AM	Novo Nordisk's 40% Fall May Be Creating A Deep-Value Moment (Benzinga)
09:57AM	Large cap pharma defensive AI winner, says RBC as it backs Lilly & AbbVie (Investing.com)
08:49AM	Can J&J Sustain Its Double-Digit Oncology Growth Streak? (Zacks)
08:26AM	Pfizer Stock: Is PFE Underperforming the Healthcare Sector? (Barchart)
Feb-24-26 04:29PM	'Stablecoin Summer': Stripe Makes Tender Offer at $159 Billion Valuation (decrypt)
02:45PM	Pfizer Secures $495 Million China Obesity Drug Deal (GuruFocus.com)
02:29PM	U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer (Business Wire)
10:44AM	Arvinas Q4 Earnings Call Highlights (MarketBeat)
09:35AM	Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity (PR Newswire)
08:27AM	What's Going On With Kyntra Bio Stock Tuesday? (Benzinga)
06:00AM	Novo to cut GLP-1 drug prices; Palvella soars on study data (BioPharma Dive)
Feb-23-26 10:45AM	Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings? (Zacks)
10:00AM	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Business Wire)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:00AM	Telescope Innovations Installs Second Self-Driving Lab at Pfizer (TMX Newsfile)
Feb-20-26 11:02AM	Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot (Benzinga)
10:46AM	AstraZeneca vs. Pfizer: Which Pharma Giant Has the Edge in 2026? (Zacks)
08:08AM	Barclays launches U.S. biopharma coverage with four preferred picks (Investing.com)
03:58AM	Analyst Report: ICU Medical, Inc. (Morningstar Research)
03:34AM	Pfizer Inc (PFE) Announces Positive Results from BREAKWATER Trial (Insider Monkey)
Feb-19-26 10:15AM	Pfizer Targets Long-Term Oncology Growth Amid Competitive Pressure (Zacks)
09:53AM	Where is Pfizer Inc. (PFE) Headed? (Insider Monkey)
Feb-18-26 11:20AM	Moderna stock surges as FDA reverses course, agrees to review new flu shot (Yahoo Finance)
03:20AM	Analyst Report: Pfizer Inc. (Morningstar Research)
Feb-17-26 11:04AM	Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk (Investor's Business Daily)
10:30AM	CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock? (Zacks)
10:15AM	Pfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer Trial (Benzinga)
06:45AM	Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer (Business Wire)
Feb-14-26 02:04PM	Oric Pharmaceuticals Highlights 2025 Milestones at Guggenheim, Targets Phase 3 Prostate Trial in 1H25 (MarketBeat)
01:28AM	Daiwa Downgrades Pfizer (PFE) to Neutral Following Full-Year 2025 Earnings (Insider Monkey)
Feb-13-26 08:57PM	Analyst Report: ICU Medical, Inc. (Morningstar Research)
04:57PM	Analyst Report: Zoetis Inc. (Morningstar Research)
09:57AM	Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds? (Insider Monkey)
Feb-12-26 12:00PM	Kahn Brothers Reduces Stake in Pfizer Inc by 21.66% (GuruFocus.com)
10:38AM	MDGL Strengthens MASH Franchise With New Genetic Approaches (Zacks)
08:00AM	Here Are Thursdays Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More (24/7 Wall St.)
Feb-11-26 01:30PM	Pfizer Reports Strong Earnings Outlook - Unusual Call Options Activity Shows Investors are Bullish (Barchart)
12:57PM	Pharma companies left out of Trump's drug-pricing deals look for way in (Reuters)
10:35AM	Pfizer (PFE) Closes 2025 on Solid Note, Returns $9.8B to Shareholders (Insider Monkey)
08:09AM	Can Pfizer's New & Acquired Drugs Offset Its Looming Patent Cliff? (Zacks)
08:01AM	CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside (Zacks)
Feb-10-26 04:51PM	Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. (Barrons.com)
11:06AM	Will BMY's Legacy Portfolio Decline Weigh on Its 2026 Top Line? (Zacks)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SAHNI PAYAL	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	82,816	Feb 27 06:35 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 25 '26	Option Exercise	33.82	122,907	4,156,715	282,186	Feb 27 06:35 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 25 '26	Option Exercise	33.82	17,558	593,812	29,744	Feb 27 06:35 PM
BOURLA ALBERT	Chairman & CEO	Feb 25 '26	Option Exercise	33.82	491,626	16,626,791	864,215	Feb 27 06:34 PM
Fonseca Lidia	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	101,579	Feb 27 06:34 PM
McDermott Michael	Executive Vice President	Feb 25 '26	Option Exercise	33.82	37,925	1,282,624	114,534	Feb 27 06:34 PM
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM

Open in Screener

KMX

Carmax Inc

Mar 12 • 04:00PM ET

41.00

-1.50 -3.53 %

Consumer Cyclical • Auto & Truck Dealerships • USA • NYSE

Peers: AN LAD PAG SAH ABG GPI TSLA GM F HOG

| Held by: IJR VTI VB VBR VXF IJS SPSM AVUV SLYV RWJ

Index	-	P/E	13.56	EPS (ttm)	3.02	Insider Own	4.12%	Shs Outstand	143.06M	Perf Week	-2.50%
Market Cap	5.81B	Forward P/E	16.50	EPS next Y	2.48	Insider Trans	0.22%	Shs Float	135.95M	Perf Month	-10.54%
Enterprise Value	23.08B	PEG	-	EPS next Q	0.18	Inst Own	103.25%	Short Float	11.05%	Perf Quarter	5.05%
Income	457.84M	P/S	0.21	EPS this Y	-17.34%	Inst Trans	-1.14%	Short Ratio	3.97	Perf Half Y	-30.73%
Sales	27.83B	P/B	0.97	EPS next Y	-6.37%	ROA	1.73%	Short Interest	15.02M	Perf YTD	6.11%
Book/sh	42.39	P/C	7.53	EPS next 5Y	-	ROE	7.46%	52W High	82.79 -50.48%	Perf Year	-43.48%
Cash/sh	5.45	P/FCF	2.98	EPS past 3/5Y	-22.80% -9.64%	ROIC	1.97%	52W Low	30.26 35.49%	Perf 3Y	-35.67%
Dividend Est.	-	EV/EBITDA	22.13	Sales past 3/5Y	-5.28% 5.66%	Gross Margin	11.31%	Volatility	5.56% 5.33%	Perf 5Y	-69.35%
Dividend TTM	-	EV/Sales	0.83	EPS Y/Y TTM	2.78%	Oper. Margin	2.50%	ATR (14)	2.12	Perf 10Y	-20.99%
Dividend Ex-Date	-	Quick Ratio	0.51	Sales Y/Y TTM	0.12%	Profit Margin	1.65%	RSI (14)	40.76	Recom	3.10
Dividend Gr. 3/5Y	- -	Current Ratio	1.99	EPS Q/Q	-47.21%	SMA20	-3.65%	Beta	1.32	Target Price	34.55
Payout	0.00%	Debt/Eq	2.98	Sales Q/Q	-6.73%	SMA50	-7.01%	Rel Volume	0.61	Prev Close	42.50
Employees	30048	LT Debt/Eq	2.84	Earnings	Dec 18 BMO	SMA200	-18.74%	Avg Volume	3.79M	Price	41.00
IPO	Feb 04, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	40.34% 2.71%	Trades		Volume	2,301,453	Change	-3.53%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-12-25	Initiated	Barclays	Underweight	$28
Nov-10-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$35
Nov-07-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-07-25	Downgrade	Needham	Buy → Hold
Nov-06-25	Downgrade	William Blair	Outperform → Mkt Perform
Nov-06-25	Downgrade	The Benchmark Company	Buy → Hold
Nov-06-25	Downgrade	JP Morgan	Neutral → Underweight	$30
Oct-07-25	Downgrade	Stephens	Overweight → Equal-Weight	$42
Sep-29-25	Downgrade	Seaport Research Partners	Buy → Neutral
Sep-26-25	Downgrade	Oppenheimer	Outperform → Perform
Sep-26-25	Downgrade	Evercore ISI	Outperform → In-line	$52
Sep-25-25	Downgrade	Wedbush	Outperform → Neutral
Aug-06-25	Upgrade	JP Morgan	Underweight → Neutral	$58
Jul-17-25	Initiated	The Benchmark Company	Buy	$75
Jul-01-25	Resumed	Morgan Stanley	Overweight	$80
May-19-25	Resumed	Wedbush	Outperform	$90
Mar-26-25	Upgrade	Stephens	Equal-Weight → Overweight	$86 → $90
Feb-06-25	Upgrade	Evercore ISI	In-line → Outperform	$90 → $110
Dec-05-24	Initiated	Stephens	Equal-Weight	$86
Mar-20-24	Upgrade	Needham	Hold → Buy	$99

Show Previous Ratings

Mar-11-26 04:20PM	Investor Starboard Sees CarMax Upside as Barr Takes Helm (Transport Topics)
02:30PM	Starboard Builds $350 Million Stake in CarMax, Seeks Board Seats (GuruFocus.com)
01:40PM	Starboard Takes $350 Million CarMax Stake, Seeks Board Seats (Bloomberg)
01:01PM	An Important Investor Has an Idea for CarMax: Charge Less for Used Cars (Investopedia)
11:29AM	Falling prices steer US buyers toward used electric vehicles (Reuters)
10:35AM	Loading…
10:35AM	CarMax Issues Statement on Engagement With Starboard Value (Business Wire)
09:58AM	CarMax Stock Edges Higher as Activist Takes Stake, Says New CEO Must 'Move Quickly' (Barrons.com)
09:34AM	Activist Starboard Pushes for Change at CarMax (The Wall Street Journal)
09:17AM	CarMax Stock: Auto Business Activist Investor Takes Stake (Investor's Business Daily)
08:00AM	Starboard Delivers Letter to CarMax (Business Wire)
Mar-06-26 10:02AM	Will Carvana's Fixed Cost Leverage Drive Its EBITDA Margin? (Zacks)
09:52AM	Will Vertical Integration Strengthen Carvana's Prospects? (Zacks)
Mar-05-26 08:03AM	Carvana's Rough Start to 2026 Post Stellar 2025: How to Play the Stock (Zacks)
Mar-04-26 08:10AM	GM merging its CPO dealer sales program with CarBravo (Wards Auto)
Mar-03-26 09:40AM	Should Value Investors Buy CarMax (KMX) Stock? (Zacks)
10:36AM	Loading…
Feb-27-26 10:36AM	CarMax Launches First-of-Its-Kind Car Shopping and Selling Experience in ChatGPT App Store (GlobeNewswire)
Feb-26-26 10:33PM	Q4 Earnings Recap: CarMax (NYSE:KMX) Tops Vehicle Retailer Stocks (StockStory)
Feb-25-26 10:10AM	Trump Trade: FedEx files suit to recoup tariff duties (TipRanks)
Feb-23-26 07:45PM	CarMax to pay $420K to resolve DOJ allegations over servicemember vehicle repossessions (Fox Business)
Feb-19-26 08:12PM	CarGurus Q4 Earnings Call Highlights (MarketBeat)
Feb-18-26 12:25PM	Why Is CarMax (KMX) Stock Soaring Today (StockStory) +8.05%
Feb-14-26 02:26PM	Carvana Drops 15% This Week: Heres The 3 Biggest Storylines (24/7 Wall St.)
Feb-13-26 08:56AM	$1 Billion Accounting Questions Cloud Carvanas 44% Sales Surge (24/7 Wall St.)
Feb-12-26 09:43AM	CarMax Taps Former Hotel CEO Keith Barr After Sales Slump (Transport Topics) -10.57%
09:00AM	Wallace Weitz Exits CarMax Inc, Impacting Portfolio by -1.58% (GuruFocus.com)
09:00AM	Eclipse backs all-EV marketplace Ever in $31M funding round (TechCrunch)
07:36AM	CarMax Names a New CEO. He's Not a Car Guy. (Barrons.com)
06:50AM	CarMax Names Keith Barr as Chief Executive Officer (Business Wire)
06:20AM	CarMax Taps Hotel Veteran to Lead Turnaround (The Wall Street Journal)
Feb-08-26 11:41PM	1 Safe-and-Steady Stock Worth Investigating and 2 We Question (StockStory)
07:30AM	Loading…
Feb-04-26 07:30AM	CarMax Named One of TIME's America's Most Iconic Companies (GlobeNewswire)
05:44AM	CarMax, Inc. (KMX) Turns to Pricing and Marketing Actions to Revitalize Sales (Insider Monkey)
Feb-03-26 11:35PM	1 Profitable Stock to Target This Week and 2 We Turn Down (StockStory)
Jan-30-26 09:24AM	Giverny Capital Asset Management Exited Its Long-Term Holding CarMax (KMX) in 2025 (Insider Monkey)
Jan-23-26 08:56AM	Should You Hold CarMax (KMX)? (Insider Monkey)
Jan-14-26 07:50AM	CarGurus Pivots Beyond Marketplace at Needham Conference, Ramping AI and Dealer Software Push (MarketBeat)
Jan-13-26 11:05PM	3 Reasons KMX is Risky and 1 Stock to Buy Instead (StockStory)
Jan-12-26 11:43AM	Why CarMax Stock Slipped 53% In 2025 (Motley Fool)
Jan-07-26 05:59AM	CarMax promises price relief for used-car customers (Wards Auto) +5.35%
Dec-31-25 09:51AM	Here's Why You Should Offload CarMax Stock From Your Portfolio (Zacks)
Dec-26-25 09:16AM	Can Carvana Stock Extend Its Strong 2025 Rally Into 2026? (Zacks)
Dec-25-25 12:31AM	The 5 Most Interesting Analyst Questions From CarMax's Q4 Earnings Call (StockStory)
Dec-22-25 08:59AM	Bear of the Day: CarMax (KMX) (Zacks)
03:34AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-20-25 10:00AM	3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500 (MarketBeat)
Dec-19-25 07:38AM	CarMax Q3 Earnings Surpass Expectations, Revenues Decline Y/Y (Zacks)
12:30AM	KMX Q4 Deep Dive: Margin Reset and Leadership Transition Dominate CarMax's Strategy (StockStory)
Dec-18-25 04:18PM	Stocks to Watch Thursday: Trump Media, Micron, Lululemon, Accenture (The Wall Street Journal)
04:01PM	CarMax Inc (KMX) Q3 2026 Earnings Call Highlights: Navigating Sales Decline and Strategic ... (GuruFocus.com)
12:57PM	CarMax Cutting Prices to Draw Car Shoppers Back (The Wall Street Journal)
12:36PM	CarMax Crashes into a Sales Slump as Amazon Circles the Used-Car Lot (GuruFocus.com)
11:53AM	These Stocks Are Moving the Most Today: Micron, DJT, Accenture, Tilray, Lululemon, Medline, Rivian, and More (Barrons.com)
10:49AM	CarMax Scores an Earnings Beat. The Stock Barely Moves. (Barrons.com)
10:46AM	Stock Market Today: Indexes Rise; Nvidia, Tesla Rally But Some Electronics Firms Struggle (Live Coverage) (Investor's Business Daily)
10:15AM	Stock Market Today: Dow, Small Caps Rise On Surprise Inflation Data; Nvidia, Tesla Rally (Live Coverage) (Investor's Business Daily)
09:37AM	Stock Market Today: Dow Rises On Surprise Inflation Data; Nvidia, Tesla Rally (Live Coverage) (Investor's Business Daily)
09:30AM	CarMax (KMX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:00AM	CarMax (KMX) Q3 Earnings and Revenues Top Estimates (Zacks)
07:40AM	CarMax flags lower margins, higher marketing spend; shares slide (Investing.com)
07:18AM	CarMax Beats Earnings Expectations. Why the Stock Is Falling. (Barrons.com)
07:16AM	CarMax Profit Sinks as Struggles Continue (The Wall Street Journal)
07:13AM	CarMax (NYSE:KMX) Beats Q4 CY2025 Sales Expectations (StockStory)
07:00AM	CarMax: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:50AM	CarMax Reports Third Quarter Fiscal Year 2026 Results (Business Wire)
05:33AM	Nike headlines Thursday's earnings slate (MarketWatch)
04:24AM	Stock Market Today: S&P 500 and Dow strive to break 4-day losing streak, Nasdaq called higher as Micron results lift tech sentiment; CPI inflation data due; Nike earnings on tap. (MarketWatch)
03:26AM	FedEx, Nike Earnings; Inflation Report: Still to Come This Week (The Wall Street Journal)
Dec-17-25 07:00PM	November CPI, Nike earnings, mortgage rates: What to Watch (Yahoo Finance Video)
Dec-16-25 10:34PM	Spotting Winners: CarMax (NYSE:KMX) And Vehicle Retailer Stocks In Q3 (StockStory)
10:01PM	CarMax Earnings: What To Look For From KMX (StockStory)
Dec-15-25 12:48PM	Reddit Investors Have No Faith in Used Car Stocks \| CVNA CARS CARG (24/7 Wall St.)
11:20AM	Tesla Owner Regrets Thinking His EV Was An 'Investment'Says He's 'Genuinely Shocked At How Much These Things Are Tanking' After Losing $750 A Month (Benzinga)
09:15AM	Stay Ahead of the Game With CarMax (KMX) Q3 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Dec-14-25 07:31AM	Trump's Fed pick comes into focus, economic data backlog clears: What to watch this week (Yahoo Finance)
05:00AM	What to Expect in Markets This Week: Jobs Report, Inflation Data, Earnings From Micron, Nike and FedEx (Investopedia)
Dec-11-25 12:29PM	Carvana Stock Is Joining the S&P 500. Should You Buy Shares Now? (Barchart)
10:00AM	Earnings Preview: CarMax (KMX) Q3 Earnings Expected to Decline (Zacks)
09:15AM	Vera Bradley (VRA) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
08:38AM	The Week Ahead: Nike, Micron Put a Bow on 2025 Earnings (Schaeffer's Research)
07:50AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-09-25 11:59AM	CarMax (KMX) Sued Over Alleged "Temporary Demand Pull-Forward" and Loan Portfolio Risk- Hagens Berman (PR Newswire)
09:00AM	CarMax, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - KMX (PR Newswire)
08:05AM	AutoZone (AZO) Q1 Earnings and Revenues Miss Estimates (Zacks)
Dec-08-25 02:39PM	Carvana Stock Heads for a New High. There's More to the Story Than S&P 500 Inclusion. (Barrons.com)
12:16PM	Carvana Stock Heads for Record Closing High. There's More to Story Than S&P 500 Inclusion. (Barrons.com)
11:30AM	Carvana stock surges on S&P 500 inclusion, marking dramatic turnaround (Yahoo Finance)
08:31AM	Here's What Affected CarMax (KMX) in Q3 (Insider Monkey)
03:15AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-05-25 08:56AM	Wedbush Says Its Time to Take Advantage and Buy the Dip in This 1 Former Meme Stock (Barchart)
Dec-04-25 08:00AM	The Week Ahead: Nike, Micron Put a Bow on 2025 Earnings (Schaeffer's Research)
Dec-03-25 02:56PM	CarMax (KMX) Sued Over Alleged "Temporary Demand Pull-Forward" and Loan Portfolio Risk- Hagens Berman (PR Newswire)
Dec-02-25 01:16PM	The Real Price of Passive: Its Not the Expense Ratio (etf.com)
Dec-01-25 03:18PM	KMX SHAREHOLDERS: CarMax, Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by January 2 (Newsfile)
Nov-30-25 02:15AM	What Every CarMax Investor Should Know Before Buying (Motley Fool)
Nov-29-25 10:48AM	Has KMX Stock Been Good for Investors? (Motley Fool)
Nov-28-25 05:55PM	CarMax, Inc. (KMX) Investor Lawsuit Filed, Shares Fall Again Amid Disclosure of Expected Comparable Store Unit Sales Decline -- Hagens Berman (PR Newswire)
07:48AM	Is CarMax (KMX) Facing Cyclical Weakness? (Insider Monkey)
Nov-25-25 05:00PM	Carmax Announces Third Quarter Conference Call (Business Wire) +5.33%
08:45AM	Investors in CarMax, Inc. Should Contact Levi & Korsinsky Before January 2, 2026 to Discuss Your Rights - KMX (PR Newswire)
Nov-24-25 02:54PM	Carvana Stock Is Rising. Ignore the Struggling Car Market, Say Analysts. (Barrons.com)

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ONeil Mark F	Director	Oct 02 '25	Buy	46.21	10,816	499,807	24,690	Oct 06 04:11 PM
STEENROD MITCHELL D	Director	Oct 02 '25	Buy	45.57	2,000	91,140	38,330	Oct 03 04:09 PM
Daniels Jon G	EVP, CAF	Jul 02 '25	Sale	70.64	1,540	108,786	2,779	Jul 03 04:11 PM
JON DANIELS	Officer	Jul 02 '25	Proposed Sale	70.64	1,540	108,790		Jul 02 04:27 PM
STEENROD MITCHELL D	Director	Apr 24 '25	Buy	65.49	1,300	85,137	33,577	Apr 25 04:08 PM

PFE

Pfizer Inc

KMX

Carmax Inc

Upgrade your FINVIZ experience